Role of ATR in Cell Cycle Checkpoints
Role of ATR in Cell Cycle Checkpoints
批准号:
7727668
负责人:
William G Dunphy
金额:
$46.67万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-01 至 2013-08-31
关键词:
AnimalsBindingBiochemicalCancer EtiologyCell CycleCell Cycle CheckpointCell Cycle ProgressionCell Cycle RegulationCell divisionCellsCheckpoint kinase 1ChemicalsChromosome abnormalityChromosomesComplexDNADNA DamageDNA Double Strand BreakDNA StructureDNA biosynthesisDNA lesionDNA replication forkDefectEnsureEnzymesEukaryotic CellExposure toGenetic MaterialsGenomeGenomicsGleanGrantHomologous GeneHumanInvestigationKnowledgeLifeMaintenanceMalignant NeoplasmsMediator of activation proteinMitoticModelingPathway interactionsPhosphorylation SitePhosphotransferasesPhysiologicalPlant RootsProcessPropertyProteinsRegulationResectedRoleSS DNA BPSignal PathwaySingle-Stranded DNAStructureSystemTREX1 geneUltraviolet RaysVertebratesWorkXenopuscopingegginsightnovelpreventpublic health relevanceresponsesensor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In eukaryotic cells, checkpoint control mechanisms prevent cell division if the genome contains stalled DNA replication forks or damaged DNA. Checkpoint pathways contain various proteins that detect problems in the genome and thereupon activate kinase-signaling pathways that control cell cycle progression. In vertebrates, the master regulatory kinase ATR functions at the apex of key checkpoint responses. ATR phosphorylates the checkpoint effector kinase Chk1 with the assistance of the mediator protein Claspin. The phosphorylated, activated form of Chk1 modulates the activity of pivotal cell cycle control enzymes in order to prohibit mitotic entry. ATR possesses a binding partner called ATRIP that interacts directly with RPA. This property enables the ATR-ATRIP complex to accumulate at various DNA lesions that share RPA-coated, single- stranded DNA as an important structural feature. However, the association of ATR-ATRIP with RPA-coated DNA is not sufficient for its activation. This observation suggested that ATR-ATRIP must interact with one or more additional components at DNA lesions in order to undergo checkpoint-dependent stimulation of its kinase activity. Recently, it has been shown that a protein known as TopBP1 functions as the direct upstream activator of the ATR-ATRIP complex. TopBP1 is a multi-functional protein that is necessary for both DNA replication and checkpoint control. Moreover, the association of TopBP1 with the checkpoint clamp comprised of Rad9-Hus1-Rad1 (the 9-1-1 complex) regulates the interaction of TopBP1 with ATR- ATRIP. These studies have revealed critical early steps in the initiation of checkpoint responses. In the upcoming grant period, a variety of studies will be carried out to examine the structure, function, and regulation of TopBP1. These investigations will be performed mostly with Xenopus egg extracts, a system that allows detailed biochemical analysis of checkpoint control mechanisms. This system also provides an excellent model for checkpoint regulation in human cells. Structure-function analyses will be carried out to elucidate the various functional domains of TopBP1 and their contribution to its regulation. In addition, mechanistic studies will be conducted to reveal how the 9-1-1 complex regulates the ability of TopBP1 to carry out the activation of ATR-ATRIP. A newly identified regulatory interaction between TopBP1 and the Mre11-Rad50-Nbs1 (MRN) complex will be also investigated. Finally, novel interactions and functions of TopBP1 at stalled replication forks will be explored. Through the study of TopBP1 in a vertebrate system that is amenable to intensive functional analysis, important insights may be gleaned into the mechanisms by which animal cells prevent the occurrence of chromosomal aberrations. PUBLIC HEALTH RELEVANCE: Cells utilize intricate surveillance or checkpoint mechanisms to ensure that their genetic material remains intact throughout life. If these regulatory mechanisms do not function properly, cells accumulate defects in their chromosomes that may ultimately result in cancer. Therefore, a thorough knowledge of checkpoint mechanisms is essential for understanding the root causes of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of ATR in Cell Cycle Checkpoints
-
批准号:6920654
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2004
-
负责人:William G Dunphy
-
依托单位:
Role of ATR in Cell Cycle Checkpoints
-
批准号:8325690
-
项目类别:
-
资助金额:$47.29万
-
财政年份:2004
-
负责人:William G Dunphy
-
依托单位:
Role of ATR in Cell Cycle Checkpoints
-
批准号:7448492
-
项目类别:
-
资助金额:$44.6万
-
财政年份:2004
-
负责人:William G Dunphy
-
依托单位:
Role of ATR in Cell Cycle Checkpoints
-
批准号:8130852
-
项目类别:
-
资助金额:$47.29万
-
财政年份:2004
-
负责人:William G Dunphy
-
依托单位:
Role of ATR in Cell Cycle Checkpoints
-
批准号:6769083
-
项目类别:
-
资助金额:$44.53万
-
财政年份:2004
-
负责人:William G Dunphy
-
依托单位:
Role of ATR in Cell Cycle Checkpoints
-
批准号:7111107
-
项目类别:
-
资助金额:$44.72万
-
财政年份:2004
-
负责人:William G Dunphy
-
依托单位:
Role of ATR in Cell Cycle Checkpoints
-
批准号:9198170
-
项目类别:
-
资助金额:$49.96万
-
财政年份:2004
-
负责人:William G Dunphy
-
依托单位:
BIO-IMAGING ANALYZER
-
批准号:2283815
-
项目类别:
-
资助金额:$18.6万
-
财政年份:1993
-
负责人:William G Dunphy
-
依托单位:
ENZYMOLOGY OF MITOSIS PROMOTING FACTOR (MPF)
-
批准号:6179747
-
项目类别:
-
资助金额:$23.04万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
ENZYMOLOGY OF MITOSIS-PROMOTING FACTOR
-
批准号:3303109
-
项目类别:
-
资助金额:$19.51万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
ENZYMOLOGY OF MITOSIS-PROMOTING FACTOR
-
批准号:3303106
-
项目类别:
-
资助金额:$20.16万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
Enzymology of Mitosis Promoting Factor (MPF)
-
批准号:6976745
-
项目类别:
-
资助金额:$36.24万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
Enzymology of Mitosis Promoting Factor (MPF)
-
批准号:6682719
-
项目类别:
-
资助金额:$30.78万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
Control of Cell Cycle Transitions
-
批准号:8434497
-
项目类别:
-
资助金额:$47.09万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
Enzymology of Mitosis Promoting Factor (MPF)
-
批准号:6829100
-
项目类别:
-
资助金额:$36.85万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
Enzymology of Mitosis Promoting Factor (MPF)
-
批准号:7740180
-
项目类别:
-
资助金额:$49.45万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
Control of Cell Cycle Transitions
-
批准号:8589592
-
项目类别:
-
资助金额:$47.09万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
ENZYMOLOGY OF MITOSIS PROMOTING FACTOR (MPF)
-
批准号:6018797
-
项目类别:
-
资助金额:$22.46万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
Enzymology of Mitosis Promoting Factor (MPF)
-
批准号:7094895
-
项目类别:
-
资助金额:$47.07万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
Control of Cell Cycle Transitions
-
批准号:8975776
-
项目类别:
-
资助金额:$47.09万
-
财政年份:1990
-
负责人:William G Dunphy
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: